PMID: 11619781Jan 1, 1997Paper

Anthrax: a malady of animals and of man which hides in the earth

Historia Medicinae Veterinariae
G Theves

Abstract

Anthrax is an infectious disease of herbivores, especially sheep and cattle, but also of horses, of pigs, of dogs, of wild animals and of humans. Bacillus anthracis causes the disease. This bacterium needs plenty of oxygen to procreate and to produce resistant spores, which remains viable in the soil during 3.5 years, at times during 15-20 years. The author tries to follow step by step the evolution of the ideas concerning the origin and the pathology as well as of the veterinarians measures against this disease during the 19th and 20th centuries. Many studies of the endemic anthrax were made from the beginning of the second half of the 19th century. Thanks to Louis Pasteur (1822-1895) in France and Robert Koch (1843-1910) in Germany, the anthrax could be identified with a soil-disease between 1870 and 1880. The statistics concerning the anthrax in the Grand-Duchy of Luxembourg compared to the geological and pedological structures of the soil, have fully confirmed the scientific findings at the end of the 19th century. Nowadays the anthrax has disappeared from our landscape thanks to the preventive inoculation and to the industrial use of the animal cadavers.

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Isis; an International Review Devoted to the History of Science and Its Cultural Influences
Susan D Jones, Philip M Teigen
© 2021 Meta ULC. All rights reserved